Different outcomes among favourable and unfavourable intermediate-risk prostate cancer patients treated with hypofractionated radiotherapy and androgen deprivation therapy

BACKGROUND: to evaluate the role of a risk stratification system in intermediate-risk prostate cancer (PCa) treated with hypofractionated radiotherapy (HyRT). METHODS: 131 patients affected by intermediate-risk PCa were treated with HyRT at the total dose of 54,75 Gy in 15 fraction plus 9 months of...

Descripción completa

Detalles Bibliográficos
Autores principales: Bracci, Stefano, Osti, Mattia F., Agolli, Linda, Bertaccini, Luca, De Sanctis, Vitaliana, Valeriani, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898326/
https://www.ncbi.nlm.nih.gov/pubmed/27276878
http://dx.doi.org/10.1186/s13014-016-0656-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898326/
https://www.ncbi.nlm.nih.gov/pubmed/27276878
http://dx.doi.org/10.1186/s13014-016-0656-0

Ejemplares similares